Urigen Pharmaceuticals, Inc.·4

Mar 18, 9:57 PM ET

Shmagin Martin E 4

4 · Urigen Pharmaceuticals, Inc. · Filed Mar 18, 2009

Insider Transaction Report

Form 4
Period: 2009-03-16
Shmagin Martin E
DirectorChief Financial Officer
Transactions
  • Purchase

    Common Stock, $.001 Par Value

    2009-03-18$0.09/sh+1,000$903,137,073 total
  • Purchase

    Common Stock, $.001 Par Value

    2009-03-16$0.08/sh+1,000$803,135,073 total
  • Purchase

    Common Stock, $.001 Par Value

    2009-03-16$0.09/sh+1,000$903,136,073 total

Documents

1 file
  • 4
    mar182009form4shamgin_ex.xmlPrimary